Emerging Microbes & Infections

Papers
(The H4-Index of Emerging Microbes & Infections is 70. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 500 papers]. The publications cover those that have been published in the past four years, i.e., from 2019-10-01 to 2023-10-01.)
ArticleCitations
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan2097
Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes1282
Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody976
Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients869
Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors746
Hypothesis for potential pathogenesis of SARS-CoV-2 infection–a review of immune changes in patients with viral pneumonia578
Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2575
Laboratory diagnosis of emerging human coronavirus infections – the state of the art538
Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension468
Emerging COVID-19 coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26452
RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak401
SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists379
Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients368
Identification of novel mobile colistin resistance gene mcr-10311
Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity308
Colistin and its role in the Era of antibiotic resistance: an extended review (2000–2019)282
A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses275
ddPCR: a more accurate tool for SARS-CoV-2 detection in low viral load specimens264
COVID-19 pandemic – an African perspective261
The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron259
Clinical observation and management of COVID-19 patients259
SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells258
Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost254
Isolation of infectious SARS-CoV-2 from urine of a COVID-19 patient248
Attenuated SARS-CoV-2 variants with deletions at the S1/S2 junction247
Development of a reverse transcription-loop-mediated isothermal amplification as a rapid early-detection method for novel SARS-CoV-2238
The different clinical characteristics of corona virus disease cases between children and their families in China – the character of children with COVID-19231
An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies231
A serological survey of SARS-CoV-2 in cat in Wuhan218
Different longitudinal patterns of nucleic acid and serology testing results based on disease severity of COVID-19 patients208
Rapid inactivation of SARS-CoV-2 with deep-UV LED irradiation203
Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells192
SARS-CoV-2 infection, disease and transmission in domestic cats184
Effectiveness of inactivated SARS-CoV-2 vaccines against the Delta variant infection in Guangzhou: a test-negative case–control real-world study183
Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic170
Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection163
Patterns of IgG and IgM antibody response in COVID-19 patients160
Experimental aerosol survival of SARS-CoV-2 in artificial saliva and tissue culture media at medium and high humidity139
SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species138
Antibody titres decline 3-month post-vaccination with BNT162b2134
Short- and potential long-term adverse health outcomes of COVID-19: a rapid review126
Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine119
Risks and features of secondary infections in severe and critical ill COVID-19 patients117
The in vitro antiviral activity of lactoferrin against common human coronaviruses and SARS-CoV-2 is mediated by targeting the heparan sulfate co-receptor116
Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection113
Antibodies in the breast milk of a maternal woman with COVID-19112
High neutralizing antibody titer in intensive care unit patients with COVID-19112
SARS-CoV-2 genomic surveillance in Taiwan revealed novel ORF8-deletion mutant and clade possibly associated with infections in Middle East108
Heterologous prime-boost: breaking the protective immune response bottleneck of COVID-19 vaccine candidates107
Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cells106
Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0)104
Emergence and spread of novel H5N8, H5N5 and H5N1 clade 2.3.4.4 highly pathogenic avian influenza in 2020104
Validation and clinical evaluation of a SARS-CoV-2 surrogate virus neutralisation test (sVNT)104
Analytical comparisons of SARS-COV-2 detection by qRT-PCR and ddPCR with multiple primer/probe sets98
Evaluating the use of posterior oropharyngeal saliva in a point-of-care assay for the detection of SARS-CoV-296
Susceptibility of rabbits to SARS-CoV-294
Genotype I African swine fever viruses emerged in domestic pigs in China and caused chronic infection94
SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease92
Gemcitabine, lycorine and oxysophoridine inhibit novel coronavirus (SARS-CoV-2) in cell culture89
Homologous or heterologous booster of inactivated vaccine reduces SARS-CoV-2 Omicron variant escape from neutralizing antibodies85
Risk factors associated with COVID-19 infection: a retrospective cohort study based on contacts tracing85
Next-generation pathogen diagnosis with CRISPR/Cas-based detection methods82
Serological differentiation between COVID-19 and SARS infections81
Non-active antibiotic and bacteriophage synergism to successfully treat recurrent urinary tract infection caused by extensively drug-resistant Klebsiella pneumoniae81
Monkeypox virus emerges from the shadow of its more infamous cousin: family biology matters80
Lack of cross-neutralization by SARS patient sera towards SARS-CoV-279
Diagnostic value and key features of computed tomography in Coronavirus Disease 201977
The first discovery of severe fever with thrombocytopenia syndrome virus in Taiwan76
Development of multi-specific humanized llama antibodies blocking SARS-CoV-2/ACE2 interaction with high affinity and avidity72
Susceptibility of swine cells and domestic pigs to SARS-CoV-272
The ongoing challenge of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis in Europe: an epidemiological analysis of bloodstream infections70
0.037545919418335